TransMedics Group, Inc.

TMDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$35-$25-$36-$44
Dep. & Amort.$20$8$3$2
Deferred Tax$0-$2$0$0
Stock-Based Comp.$33$20$10$7
Change in WC-$45-$44-$27$3
Other Non-Cash$5$30$3$4
Operating Cash Flow$49-$13-$46-$29
Investing Activities
PP&E Inv.$0-$152-$12-$4
Net Acquisitions$0-$15$0$0
Inv. Purchases$0$0-$10-$72
Inv. Sales/Matur.$0$0$77$105
Other Inv. Act.-$130-$27-$0$0
Investing Cash Flow-$129-$194$55$29
Financing Activities
Debt Repay.$0$445$22$0
Stock Issued$23$0$140$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$45$6$1
Financing Cash Flow$23$400$168$1
Forex Effect-$1$0-$1-$1
Net Chg. in Cash-$58$194$176$1
Supplemental Information
Beg. Cash$395$202$26$25
End Cash$337$395$202$26
Free Cash Flow-$81-$192-$58-$32
TransMedics Group, Inc. (TMDX) Financial Statements & Key Stats | AlphaPilot